bg
A

Allogene (ALLO)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Allogene (ALLO)

Allogene Therapeutics, Inc. is a clinical stage immuno-oncology company. The Company is focused on developing and commercializing of allogeneic T cell therapies for the treatment of cancer. It is involved in developing a pipeline of multiple allogene... Read more

  • USD3.00
  • USD3.01
  • USD2.77
  • USD6.41
  • -14.00%
  • 0M
  • 2.51M
  • 2.26M
  • 471M
  • 2.23
  • -50.90%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.